A Study to Evaluate the Effect of Food on the Bioavailability of AJ201, and Safety, Tolerability, and Pharmacokinetics of AJ201 in Japanese and White Healthy Male Participants

This is a Phase 1, randomized, single-dose, open-label, two-way crossover study to evaluate the effect of food on AJ201, and to evaluate the safety, tolerability, and pharmacokinetics of AJ201 in Japanese and White healthy male participants.

NCT Number	NCT07549919
Lead Sponsor	AnnJi Pharmaceutical Co., Ltd.
Conditions	Healthy Male Adults, Food Effect in Healthy Volunteers
Enrollment	26 participants
Start Date	2026-04-09
Primary Completion	2026-04-22 (estimated)
Study Completion	2026-04-27 (estimated)
Updated on ClinicalTrials.gov	2026-04-24